Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BENZODIAZEPINES TOXICOLOGY CONTROL

K-Number: K862418 · 1986-11-13

ApplicantUtak Laboratories, Inc.
Decision Date1986-11-13
Product CodeLAS
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

BENZODIAZEPINES TOXICOLOGY CONTROL is the device name listed in this FDA 510(k) record. The listed applicant is Utak Laboratories, Inc.. It received FDA 510(k) clearance on 1986-11-13 under 510(k) number K862418. The device is classified under product code LAS. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BENZODIAZEPINES TOXICOLOGY CONTROL?

BENZODIAZEPINES TOXICOLOGY CONTROL is a medical device that received FDA 510(k) clearance on 1986-11-13. The listed applicant is Utak Laboratories, Inc.. The 510(k) number is K862418.

When did BENZODIAZEPINES TOXICOLOGY CONTROL receive FDA 510(k) clearance?

BENZODIAZEPINES TOXICOLOGY CONTROL received FDA 510(k) clearance on 1986-11-13, under 510(k) number K862418.

Who is the listed applicant for BENZODIAZEPINES TOXICOLOGY CONTROL?

The FDA 510(k) record lists Utak Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BENZODIAZEPINES TOXICOLOGY CONTROL?

The FDA product code for BENZODIAZEPINES TOXICOLOGY CONTROL is LAS.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Utak Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K903061UTAK LABORATORIES TOXICOLOGY CONTROLK883147TRACE ELEMENTS SERUM TOXICOLOGY CONTROLK862419SERUM VANCOMYCIN TOXICOLOGY CONTROLK862421SERUM CLONAZEPAM TOXICOLOGY CONTROLK862420UTAK-STABBS TOXICOLOGY CONTROLK831736TRICYCLIC ANTIDEPRESSANTS

View all 23 devices →

Related Devices (Code: LAS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K080459CHROMESYTEMS TOXICOLOGY CALIBRATORS AND CONTROLSChromsystems Instruments & Chemicals GmbHK072257MYCOPHENOLIC ACID CONTROL, LEVEL 1, 2, 3, 4, 4-LEVELMore DiagnosticsK062942QUANTIMETRIX NICOSURE COTININE URINE CONTROLQuantimetrix Corp.K051074MAS IMMUNOSUPPRESSANT CONTROLSMicrogenics Corp.K040411DRI OXYCODONE ASSAYMicrogenics Corp.K032842MICROGENICS CYCLOSPORINE CONTROL KITMicrogenics Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑